These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 20099569)

  • 1. Relation between 25(OH)-vitamin D deficiency and markers of bone formation and resorption in haemodialysis patients.
    Milinković NLj; Majkić-Singh NT; Mirković DD; Beletić AD; Pejanović SD; Vujanić ST
    Clin Lab; 2009; 55(9-10):333-9. PubMed ID: 20099569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.
    Bielesz BO; Hecking M; Plischke M; Cejka D; Kieweg H; Haas M; Marculescu R; Hörl WH; Bieglmayer C; Sunder-Plassmann G
    Clin Biochem; 2014 Sep; 47(13-14):1316-9. PubMed ID: 24956265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum beta-type I collagen carboxyterminal telopeptide (beta-CTXs) and bone involvement in chronic renal failure].
    Oliveri B; Wittich AC; Nadal MA; Zeni SN
    Medicina (B Aires); 2005; 65(4):321-8. PubMed ID: 16193710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased levels of osteoprotegerin in hemodialysis patients.
    Avbersek-Luznik I; Malesic I; Rus I; Marc J
    Clin Chem Lab Med; 2002 Oct; 40(10):1019-23. PubMed ID: 12476941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of bone alkaline phosphatase and iPTH with some basic biochemical markers in predialysis and dialysis patients.
    Milinković NL; Majkic-Singh NT; Ignjatović SD; Lezaić VD; Pejanović SD; Jovanovic DB
    Clin Lab; 2012; 58(7-8):747-53. PubMed ID: 22997975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory effect of parathyroid hormone on sRANKL-osteoprotegerin in hemodialysis patients with renal bone disease.
    Doumouchtsis K; Perrea D; Doumouchtsis S; Tziamalis M; Poulakou M; Vlachos I; Kostakis A
    Ther Apher Dial; 2009 Feb; 13(1):49-55. PubMed ID: 19379170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.
    Haarhaus M; Monier-Faugere MC; Magnusson P; Malluche HH
    Am J Kidney Dis; 2015 Jul; 66(1):99-105. PubMed ID: 25843703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of haemodialysis on markers of bone turnover in children.
    Waller S; Ridout D; Rees L
    Pediatr Nephrol; 2007 Apr; 22(4):586-92. PubMed ID: 17216258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating bone turnover markers and their relationships in hemodialysis patients with vitamin D deficiency].
    Kulicki P; Żebrowski P; Sokalski A; Klatko W; Birecka M; Mieczkowski M; Niemczyk S; Małyszko J; Matuszkiewicz-Rowińska J
    Wiad Lek; 2019; 72(11 cz 2):2202-2209. PubMed ID: 31860837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecalciferol supplementation reduces soluble Klotho concentration in hemodialysis patients.
    Hryszko T; Rydzewska-Rosołowska A; Goździkiewicz J; Brzósko S; Koc-Żórawska E; Zelazowska-Rutkowska B; Myśliwiec M
    Pol Arch Med Wewn; 2013; 123(6):277-81. PubMed ID: 23673970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
    Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
    Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.
    Sprague SM; Bellorin-Font E; Jorgetti V; Carvalho AB; Malluche HH; Ferreira A; D'Haese PC; Drüeke TB; Du H; Manley T; Rojas E; Moe SM
    Am J Kidney Dis; 2016 Apr; 67(4):559-66. PubMed ID: 26321176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy in dialyzed children.
    Baskin E; Beşbaş N; Saatçi U; Hasçelik G; Topaloğlu R; Ozen S; Bakkaloğlu A
    Turk J Pediatr; 2004; 46(1):28-31. PubMed ID: 15074371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of bone metabolism related hormones to a single session of strenuous exercise in active elderly subjects.
    Maïmoun L; Simar D; Malatesta D; Caillaud C; Peruchon E; Couret I; Rossi M; Mariano-Goulart D
    Br J Sports Med; 2005 Aug; 39(8):497-502. PubMed ID: 16046330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of different bone markers in hemodialyzed patients.
    Cavalier E; Delanaye P; Collette J; Krzesinski JM; Chapelle JP
    Clin Chim Acta; 2006 Sep; 371(1-2):107-11. PubMed ID: 16600202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.